We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · September 22, 2020

Clinical Outcomes of COVID-19 in Patients Taking Tumor Necrosis Factor Inhibitors and/or Methotrexate

Journal of the American Academy of Dermatology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of the American Academy of Dermatology
Clinical Outcomes of CoVid-19 in Patients Taking Tumor Necrosis Factor Inhibitors and/or Methotrexate: A Multi-Center Research Network Study
J Am Acad Dermatol 2020 Sep 11;[EPub Ahead of Print], A Yousaf, S Gayam, S Feldman, Z Zinn, M Kolodney

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading